Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19-Reference-Cited by-同舟云学术

Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19

Published:2023-01-04 Issue:2 Volume:12 Page:563-575
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Meng Qing,Li Wujiao,Jiang Hanfang,Yan Huimin,Wang Heping,Ye Binjun,Zhou Lintao,Chen Yunsheng^ORCID

Funder

Guangdong Provincial High-level Hospital Construction Special Fund

Guangdong High-level Hospital Construction Fund

the Research Grants for Postdocs Settle in Shenzhen from Shenzhen Government

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-022-00751-4.pdf

Reference18 articles.

1. Leber AL, editor. 2016 update: clinical microbiology procedures handbook. 4th ed. Washington, DC: ASM Press; 2016.

2. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. M100 28th edition. Wayne: Clinical and Laboratory Standards Institute; 2021.

3. Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. M45 3rd edition. Wayne: Clinical and Laboratory Standards Institute; 2016.

4. U.S. Food and Drug Administration. FDA-identified interpretive criteria [S/OL]. [2022-10-30]. https://www.fda.gov/drugs/development-resources/tigecycline-injection-products.

5. Jones RN, Barry AL, Packer RR, Gregory WW, Thornsberry C. In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone–sulbactam combination. J Clin Microbiol. 1987;25(9):1725–9.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in the Antimicrobial Resistance and Bacterial Epidemiology of Moraxella catarrhalis from Pediatric Community-Acquired Pneumonia Patients During the COVID-19 Pandemic: A 5-Year Study at a Tertiary Hospital of Southwest China;Microbial Drug Resistance;2024-08-09

2. Changes in the epidemiology and antimicrobial resistance patterns of Streptococcus pneumoniae from pediatric community acquired pneumonia patients attended in a Chinese hospital during the COVID-19 pandemic;Infection;2024-06-07

3. Impact of the COVID-19 pandemic on Haemophilus influenzae infections in pediatric patients hospitalized with community acquired pneumonia;Scientific Reports;2024-06-03

4. Epidemiologic analysis of antimicrobial resistance in hospital departments in China from 2022 to 2023;Journal of Health, Population and Nutrition;2024-03-06

5. Editorial: Emerging pneumonia and acute lower respiratory infections in children, volume II;Frontiers in Pediatrics;2024-02-01